Eli Lilly to invest $4.5 billion in integrated drug discovery and manufacturing facility
Eli Lilly and Company has announced plans for a $4.5 billion (£3.6 billion) facility that integrates pharmaceutical research and manufacturing. The Lilly Medicine Foundry, revealed on 2 October 2024, will aim to streamline drug discovery and production processes. This approach could significantly accelerate the journey from drug development through clinical trials to manufacturing.
